A recent study reported that TREM2 deficiency has a disease-progression-dependent effect on amyloid pathology by ameliorating amyloid pathology early but exacerbating it late in AD in APPPS1-21 mice [55]. This evidence concerns the gene TREM2 and amyloidosis.